ID: h-5de005be
Hypothesis
PU.1 Degradation via PROTAC for Inflammatory Microglial Polarization
NOT RECOMMENDED.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 4 support✗ 4 oppose
✓ All Quality Gates Passed
🧪 Overview
NOT RECOMMENDED. Critical safety contraindications: PU.1 knockout is embryonic lethal in mice; PU.1 haploinsufficiency in humans causes neutropenia and immunodeficiency. The hypothesis contains a mechanistic paradox: Keren-Shaul et al. (PMID:29445926) demonstrates PU.1 directly regulates TREM2 expression and is REQUIRED for DAM formation. Degrading PU.1 would eliminate the protective DAM state entirely, contradicting therapeutic intent. PROTAC chemistry is validated (ARV-471, ARV-110), but this target is wrong.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Amyloid-beta Plaques<br/>Phospholipid Ligands"]
B["TREM2 Receptor<br/>Ligand Binding"]
C["TYROBP/DAP12<br/>ITAM Phosphorylation"]
D["SYK Kinase<br/>Activation"]
E["PLCG2<br/>IP3 + DAG Generation"]
F["Ca2+ Release<br/>Cytoskeletal Remodeling"]
G["Microglial Phagocytosis<br/>Plaque Compaction"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
⚖️ Evidence Matrix4 supports4 contradicts
Supports
PU.1 drives inflammatory gene expression in microglia via chromatin accessibility
Contradicts
PU.1 directly regulates TREM2 expression; degrading PU.1 would eliminate DAM entirely
Contradicts
PU.1 siRNA studies show modest phenotypes, suggesting compensatory mechanisms
Contradicts
PU.1 controls >1,000 genes in myeloid cells; complete degradation would cause immune deficiency
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — PU.1
No curated PDB or AlphaFold mapping for PU.1 yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for PU.1 Degradation via.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.7%
Volatility
Medium
0.0278
Events (7d)
2
Price History
▲14.7%💾 Resource Usage
LLM Tokens
32,048
$0.0961
Total Cost
$0.0961
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF PU.1 is systemically degraded via PROTAC in adult mice with established neurodegeneration, THEN motor performance (rotarod latency), amyloid plaque burden, or neuronal survival will NOT improve rel | No improvement in behavioral deficits (rotarod latency <180 seconds), no reduction in amyloid plaque area (≥5% of cortical area), and continued neuronal loss in | — no observation — | pending | 0.12 |
| IF PU.1 is degraded using a PROTAC approach in primary microglia cultures or in vivo mouse models of neurodegeneration (5xFAD, METH model), THEN inflammatory M1 polarization markers (CD16/CD32 surface | Increased or unchanged M1 inflammatory markers (CD16/32 upregulation ≥1.5-fold, IL-6 ≥50 pg/mL, TNF-α ≥100 pg/mL) rather than the expected anti-inflammatory M2 | — no observation — | pending | 0.15 |
🔮 Falsifiable Predictions (2)
pendingconf 15%
IF PU.1 is degraded using a PROTAC approach in primary microglia cultures or in vivo mouse models of neurodegeneration (5xFAD, METH model), THEN inflammatory M1 polarization markers (CD16/CD32 surface expression, IL-6, TNF-α, iNOS mRNA) will NOT decrease relative to vehicle control, but rather incre
Predicted outcome: Increased or unchanged M1 inflammatory markers (CD16/32 upregulation ≥1.5-fold, IL-6 ≥50 pg/mL, TNF-α ≥100 pg/mL) rather than the expected anti-inflam
Falsification: Significant reduction in M1 markers (>30% decrease in CD16/32+, IL-6, TNF-α) and increase in M2 markers (Arg1, Ym1, CD206) would disprove the mechanistic paradox; alternatively, PU.1 degradation witho
pendingconf 12%
IF PU.1 is systemically degraded via PROTAC in adult mice with established neurodegeneration, THEN motor performance (rotarod latency), amyloid plaque burden, or neuronal survival will NOT improve relative to vehicle-treated controls, but worsen or remain stable, within 8-12 weeks of continuous dosi
Predicted outcome: No improvement in behavioral deficits (rotarod latency <180 seconds), no reduction in amyloid plaque area (≥5% of cortical area), and continued neuron
Falsification: Significant improvement in motor function (>40% increase in rotarod latency), ≥25% reduction in plaque load, or preservation of NeuN+ neurons compared to vehicle would disprove the hypothesis that PU.
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.